Europol calls India out for not policing drug counterfeiters; CPhI adds experts from Catalent, Piramal, IMS;

> A new report written in part by Europol takes India to task for not doing more to interrupt the manufacture of counterfeit meds that are ending up in Europe. Report

> CPhI has added Kurt Nielson of Catalent ($CTLT); Vivek Sharma of Piramal; and Alan Sheppard of IMS Health ($IMS) to its panel of experts for evaluating supply-chain trends. Release

> The European Federation of Pharmaceutical Industries and Associations says more flexibility in the EU's GMP guidance on qualification and validation would promote new technologies in the future. Report

Suggested Articles

Gilead Sciences will add 140 jobs to its Irish operations as part of an expansion to its Dublin distribution center, the Irish Times reported.

GSK's Shingrix supply has recovered after COVID-19 prompted a slowdown in vaccinations.

Moderna will delegate fill-finish duties for "hundreds of millions" of doses of its COVID-19 vaccine to Spain's Laboratorios Farmacéuticos Rovi.